CPX
NXTC icon

Canaan Partners X’s NextCure NXTC Stock Holding History

Canaan Partners X’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-26,804
Closed -$2.17M – 5
2021
Q3 		$2.17M Sell
26,804
-43,066
-62% -$3.78M 0.62% 4
2021
Q2 		$6.73M Hold
69,870
– – 10.11% 2
2021
Q1 		$8.39M Hold
69,870
– – 11.44% 2
2020
Q4 		$9.14M Sell
69,870
-72,756
-51% -$9.4M 19% 2
2020
Q3 		$15.1M Sell
142,626
-26,411
-16% -$3.25M 29.94% 2
2020
Q2 		$43.5M Hold
169,037
– – 52.17% 1
2020
Q1 		$75.2M Sell
169,037
-18,833
-10% -$10.1M 82.76% 1
2019
Q4 		$127M Buy
+187,870
New +$94.2M 82.06% 1

Other funds holding NXTC

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return